Cargando…

Establishment of a clinical SPECT/CT protocol for imaging of (161)Tb

BACKGROUND: It has been proposed, and preclinically demonstrated, that (161)Tb is a better alternative to (177)Lu for the treatment of small prostate cancer lesions due to its high emission of low-energy electrons. (161)Tb also emits photons suitable for single-photon emission computed tomography (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Marin, I., Rydèn, T., Van Essen, M., Svensson, J., Gracheva, N., Köster, U., Zeevaart, J. R., van der Meulen, N. P., Müller, C., Bernhardt, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329978/
https://www.ncbi.nlm.nih.gov/pubmed/32613587
http://dx.doi.org/10.1186/s40658-020-00314-x
Descripción
Sumario:BACKGROUND: It has been proposed, and preclinically demonstrated, that (161)Tb is a better alternative to (177)Lu for the treatment of small prostate cancer lesions due to its high emission of low-energy electrons. (161)Tb also emits photons suitable for single-photon emission computed tomography (SPECT) imaging. This study aims to establish a SPECT protocol for (161)Tb imaging in the clinic. MATERIALS AND METHODS: Optimal settings using various γ-camera collimators and energy windows were explored by imaging a Jaszczak phantom, including hollow-sphere inserts, filled with (161)Tb. The collimators examined were extended low-energy general purpose (ELEGP), medium-energy general purpose (MEGP), and low-energy high resolution (LEHR), respectively. In addition, three ordered subset expectation maximization (OSEM) algorithms were investigated: attenuation-corrected OSEM (A-OSEM); attenuation and dual- or triple-energy window scatter-corrected OSEM (AS-OSEM); and attenuation, scatter, and collimator-detector response-corrected OSEM (ASC-OSEM), where the latter utilized Monte Carlo-based reconstruction. Uniformity corrections, using intrinsic and extrinsic correction maps, were also investigated. Image quality was assessed by estimated recovery coefficients (RC), noise, and signal-to-noise ratio (SNR). Sensitivity was determined using a circular flat phantom. RESULTS: The best RC and SNR were obtained at an energy window between 67.1 and 82.1 keV. Ring artifacts, caused by non-uniformity, were removed with extrinsic uniformity correction for the energy window between 67.1 and 82.1 keV, but not with intrinsic correction. Analyzing the lower energy window between 48.9 and 62.9 keV, the ring artifacts remained after uniformity corrections. The recovery was similar for the different collimators when using a specific OSEM reconstruction. Recovery and SNR were highest for ASC-OSEM, followed by AS-OSEM and A-OSEM. When using the optimized parameter setting, the resolution of (161)Tb was higher than for (177)Lu (8.4 ± 0.7 vs. 10.4 ± 0.6 mm, respectively). The sensitivities for (161)Tb and (177)Lu were 7.41 and 8.46 cps/MBq, respectively. CONCLUSION: SPECT with high resolution is feasible with (161)Tb; however, extrinsic uniformity correction is recommended to avoid ring artifacts. The LEHR collimator was the best choice of the three tested to obtain a high-resolution image. Due to the complex emission spectrum of low-energy photons, window-based scatter correction had a minor impact on the image quality compared to using attenuation correction only. On the other hand, performing attenuation, scatter, and collimator-detector correction clearly improved image quality. Based on these data, SPECT-based dosimetry for (161)Tb-labeled radiopharmaceuticals is feasible.